Expanded characterization of CD3-binding antibodies includes identification of antibodies that bind regions of CD3 that are distinct from commonly used molecules Robust proof-of-concept study demonstrates T-cell engagers that potently eliminate… Read More
CPHI Award recognizes cross-industry innovators Collaboration with Stanford University Maximizing potential of mRNA therapeutics ESSEN, DE — Evonik Health Care has won the prestigious CPHI Excellence in Pharma Award in… Read More
Michael Smith Health Research BC’s Scholar and Research Trainee awards provide funding to support BC’s next generation of health researchers in advancing science and improving the health of British Columbians…. Read More
Funding will support the first active comparator, multicentre, randomized trial to evaluate optimal first-line treatment strategy for Ileal Crohn’s disease TORONTO, ON — The Canadian Inflammatory Bowel Disease Research Consortium… Read More
The Discovery Group is expanding its team by bringing on Vivian Wang as Investment Associate at Nimbus Synergies. Vivian will be joining Nimbus Synergies in a full-time capacity as she… Read More
